A novel intracellular nanobody against HPV16 E6 oncoprotein. PMID: 33549834
High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells. PMID: 9742507
Novel Lentivirus-Based Method for Rapid Selection of Inhibitory Nanobody against PRRSV. PMID: 32092857
Nanobodies as binding-chaperones stabilize the recombinant Bombyx mori acetylcholinesterase and protect the enzyme activity in pesticide detection. PMID: 35114480
Development of nanobody-horseradish peroxidase-based sandwich ELISA to detect Salmonella Enteritidis in milk and in vivo colonization in chicken. PMID: 35361208
Influence of Nb on the Microstructure and Fracture Toughness of (Zr0.76Fe0.24)100-xNbx Nano-Eutectic Composites. PMID: 29324694
Photodynamic therapy with 5-aminolevulinic acid: A new diagnostic, therapeutic, and surgical aid for neuroblastoma. PMID: 35396087
Synergistic regulation mechanism of iperoxo and LY2119620 for muscarinic acetylcholine M2 receptor. PMID: 35542505
Structural basis of nanobody-mediated blocking of BtuF, the cognate substrate-binding protein of the Escherichia coli vitamin B12 transporter BtuCD. PMID: 29084999
The far-infrared spectra of neutral and cationic niobium clusters: Nb5 0/+ to Nb9 0+. PMID: 18154381
MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells. PMID: 18813796
Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon. PMID: 24626568
Depletion of TFAP2E attenuates adriamycin-mediated apoptosis in human neuroblastoma cells. PMID: 28260105
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells. PMID: 33378961
Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells. PMID: 9626582
Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. PMID: 15961194
Isomer selective infrared spectroscopy of neutral metal clusters. PMID: 15836105
Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. PMID: 3858848
Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics. PMID: 16546710
Electronic structures, vibrational and thermochemical properties of neutral and charged niobium clusters Nb(n), n = 7-12. PMID: 21446686
How accurately can a single molecule be localized in three dimensions using a fluorescence microscope? PMID: 20448826
Amplification of IMR-32 clones 8, G21, and N-myc in human neuroblastoma xenografts. PMID: 3034408
Molecular epidemiology of human papillomavirus variants in cervical cancer in India., PMID:39913513
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study., PMID:39913364
Human Papillomavirus Type 16 E6 Seroprevalence among Men Living with HIV without HPV-Driven Malignancies., PMID:39907040
Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?, PMID:39899908
Natural history of HPV-16 E6 serology among cancer-free men in a multicenter longitudinal cohort study., PMID:39658222
[A fluorescence immunochromatography method for detection of human papillomavirus type 16 E6 and L1 proteins]., PMID:39584350
CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer., PMID:39524212
HPV16 mutant E6/E7 construct is protective in mouse model., PMID:39350162
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers., PMID:38978164
Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status., PMID:38577820
Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis., PMID:38542409
A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses., PMID:37895145
Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex., PMID:37694289
Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines., PMID:37626903
Immune Status of Cervical Lymph Nodes in Head and Neck Cancer-A Surgical Oncology Perspective., PMID:37511787
HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study., PMID:37289012
Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study., PMID:37032449
Human papilloma virus-16-specific CD8+ T-cell expansions characterize different clinical forms of lichen planus and not lichen sclerosus et atrophicus., PMID:36922453
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16., PMID:36780000
Human papillomavirus is an important risk factor for esophageal carcinoma in a Chinese population., PMID:36394699
Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study., PMID:36147627
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium., PMID:35700419
A dual-signal electrochemical immunosensor for the detection of HPV16 E6 oncoprotein based on PdBP dendritic ternary nanospheres and MBSi-Chi nanocomposites., PMID:35510624
Human Papillomavirus 16 E6 Suppresses Transporter Associated with Antigen-Processing Complex in Human Tongue Keratinocyte Cells by Activating Lymphotoxin Pathway., PMID:35454851
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay., PMID:35225653
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer., PMID:34642315
Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies., PMID:34502053
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers., PMID:34432728
Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis., PMID:34208476
ePCL Electrospun Microfibrous Layers for Immune Assays: Sensitive ELISA for the Detection of Serum Antibodies Against HPV16 E7 Oncoprotein., PMID:33842749
Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000., PMID:33721332
Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009., PMID:33651712
A novel intracellular nanobody against HPV16 E6 oncoprotein., PMID:33549834
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors., PMID:33485370
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer., PMID:33426652
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens., PMID:33335126
Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank., PMID:33248371
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model., PMID:33108473
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)., PMID:32918586
Humoral Response to HPV16 Proteins in Persons with Anal High-Grade Squamous Intraepithelial Lesion or Anal Cancer., PMID:32883662
The Protective Effect of Antioxidants in Areca Nut Extract-Induced Oral Carcinogenesis., PMID:32856877
Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs., PMID:32640530
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine., PMID:32554612
[Expression of HPV16 E6 recombinant protein and preparation of its rabbit polyclonal antibody]., PMID:32389175
Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670
Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer., PMID:32129894
Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma., PMID:32101350
For research use only. Not for human or drug use.
